Brooke Marie Matney

Array ( [id] => 6031110 [patent_doc_number] => 20110081375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'CHIMERIC ADENOVIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 12/945358 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15660 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081375.pdf [firstpage_image] =>[orig_patent_app_number] => 12945358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9642579 [patent_doc_number] => 20140220690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'MAMMALIAN GENES INVOLVED IN INFECTION' [patent_app_type] => utility [patent_app_number] => 13/877247 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23054 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943498 [patent_doc_number] => 20110104118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR THERAPEUTIC USE' [patent_app_type] => utility [patent_app_number] => 12/912496 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6489 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104118.pdf [firstpage_image] =>[orig_patent_app_number] => 12912496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9060208 [patent_doc_number] => 08546644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen stress and the use thereof' [patent_app_type] => utility [patent_app_number] => 12/879931 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12879931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336048 [patent_doc_number] => 20120202751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHODS OF MONITORING ENDOPLASMIC RETICULUM (ER) STRESS RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/389765 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 12860 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5982571 [patent_doc_number] => 20110072524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A' [patent_app_type] => utility [patent_app_number] => 12/850243 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20110072524.pdf [firstpage_image] =>[orig_patent_app_number] => 12850243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189724 [patent_doc_number] => 20120117669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENOMICE' [patent_app_type] => utility [patent_app_number] => 12/837454 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12672 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20120117669.pdf [firstpage_image] =>[orig_patent_app_number] => 12837454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6141410 [patent_doc_number] => 20110010786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'TRANSGENIC ANIMAL EXPRESSING B CELL ANTIGEN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/833287 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6107 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20110010786.pdf [firstpage_image] =>[orig_patent_app_number] => 12833287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087781 [patent_doc_number] => 20110217266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Genomic sequence of avian paramyxovirus type 2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/803165 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 45643 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217266.pdf [firstpage_image] =>[orig_patent_app_number] => 12803165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834353 [patent_doc_number] => 08450108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Surgical device for skin therapy or testing' [patent_app_type] => utility [patent_app_number] => 12/818302 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5973 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12818302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629680 [patent_doc_number] => 08361751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost' [patent_app_type] => utility [patent_app_number] => 12/782782 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39877 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12782782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403819 [patent_doc_number] => 20100305307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/767086 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 37683 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305307.pdf [firstpage_image] =>[orig_patent_app_number] => 12767086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6482306 [patent_doc_number] => 20100192235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA MODELED IN MOUSE BY TARGETED TCL1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/758177 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8032 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20100192235.pdf [firstpage_image] =>[orig_patent_app_number] => 12758177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095448 [patent_doc_number] => 20110002980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'VACCINES USING NUCLEIC ACID-LIPID COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/757001 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20114 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002980.pdf [firstpage_image] =>[orig_patent_app_number] => 12757001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320312 [patent_doc_number] => 20100196339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Microparticle-Based Transfection and Activation of Dendritic Cells' [patent_app_type] => utility [patent_app_number] => 12/755266 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10418 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196339.pdf [firstpage_image] =>[orig_patent_app_number] => 12755266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519555 [patent_doc_number] => 20100203074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 12/722167 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 35168 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203074.pdf [firstpage_image] =>[orig_patent_app_number] => 12722167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549287 [patent_doc_number] => 20100233119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'SUPPRESSION OF IMMUNE RESPONSE TO FACTOR VIII IN HEMOPHILIA A PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/721361 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15627 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233119.pdf [firstpage_image] =>[orig_patent_app_number] => 12721361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328679 [patent_doc_number] => 08236776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Modified CEA nucleic acid and expression vectors' [patent_app_type] => utility [patent_app_number] => 12/716239 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13704 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12716239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574170 [patent_doc_number] => 20110269826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 13/128813 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17931 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269826.pdf [firstpage_image] =>[orig_patent_app_number] => 13128813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994509 [patent_doc_number] => 08518391 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-27 [patent_title] => 'Monocytes as a gene delivery vector for secreted proteins to treat Alzheimer\'S disease' [patent_app_type] => utility [patent_app_number] => 12/610815 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4929 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12610815 [rel_patent_id] =>[rel_patent_doc_number] =>)